<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00234962</url>
  </required_header>
  <id_info>
    <org_study_id>PUER-01-001</org_study_id>
    <nct_id>NCT00234962</nct_id>
  </id_info>
  <brief_title>Study of Adherence Effects and Clinical Outcomes of Kaletra Based HIV Antiviral Therapy</brief_title>
  <official_title>Factors Associated With Adherence in a Cohort of HIV Positive Subjects on a First Time PI Containing HAART Regimen: Observational Study of the Impact of Adherence on Viral Load for a HAART Regimen Containing Kaletra vs Other Selected PI Containing HAART.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Abbott</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Abbott</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the effects of adherence on HIV antiviral response
      to treatment regimens containing Kaletra or other HIV protease inhibitors.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <start_date>August 2002</start_date>
  <completion_date type="Actual">February 2007</completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Antiviral efficacy by HIV RNA</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Treatment related discontinuations, predictors of adherence</measure>
  </secondary_outcome>
  <enrollment>200</enrollment>
  <condition>HIV Infection</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lopinavir/Ritonavir</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject is documented HIV positive

          -  Subject is greater than or equal to 18 years of age.

          -  Subject currently on a regimen of either NNRTI + 2 Nucleoside Reverse Transcriptase
             Inhibitors NRTIs), two or three NRTIs who have failed regimen as evidenced by two
             consecutive viral loads with values over 1,000 copies/mL, the last one within the last
             three months, or

          -  Na√Øve subjects to ARV regimen who are required to begin a PI containing HAART regimen,
             or

          -  Subjects who have become intolerant to their current antiretroviral regimen and are
             required to be changed to a first time PI containing HAART regimen.

          -  Subject had laboratory testing within the previous three months and the most recent
             testing demonstrates all of the following: Hemoglobin &gt;8.0 g/dL; Absolute neutrophil
             count &gt;750 cells/mL; Platelet count &gt;20,000/mL; ALT or AST &lt;3 x Upper Limit of Normal
             (ULN); Creatinine &lt;1.5 x ULN; Triglycerides &lt;750 mg/dL.

          -  Subjects have no have evidence of grade III or IV adverse event or laboratory
             abnormality.

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Global Medical Information</last_name>
    <role>Study Director</role>
    <affiliation>Abbott</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Global Medical Information - Abbott</name>
      <address>
        <city>North Chicago</city>
        <state>Illinois</state>
        <zip>60064</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 13, 2005</study_first_submitted>
  <study_first_submitted_qc>October 7, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 10, 2005</study_first_posted>
  <last_update_submitted>November 19, 2008</last_update_submitted>
  <last_update_submitted_qc>November 19, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 21, 2008</last_update_posted>
  <keyword>HIV Infection</keyword>
  <keyword>HAART</keyword>
  <keyword>Lopinavir</keyword>
  <keyword>Ritonavir</keyword>
  <keyword>Treatment Experienced</keyword>
  <keyword>Treatment Naive</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>HIV Infections</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ritonavir</mesh_term>
    <mesh_term>Lopinavir</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

